Edwards Lifesciences Corporation (EW) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Edwards Lifesciences Corporation  (NYSE: EW)


Edwards Lifesciences's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Edwards Lifesciences's ROI in the second quarter of 2026?
Edwards Lifesciences Corporation achieved a return on average invested assets (ROI) of 8.39 % in its second quarter of 2026, which is below Edwards Lifesciences's average return on investment, which stands at 19.31%.

ROI decreased relative to the period ending Mar 31 2026, due to the decline in net income.

Within the Healthcare sector 117 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 804 to 928.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 2.81 % 9.87 % 17.48 % 28.52 % 37.77 %
Y / Y Net Income Change TTM -75.77 % -73.8 % -72 % -60.33 % 1034.68 %
Investment (TTM) in Millions 12,370 11,912 11,884 11,684 12,145
Return On Investment (TTM) 8.39 % 9.19 % 9.02 % 11.56 % 35.59 %
EW's Overall Ranking # 928 # 804 # 793 # 636 # 117
Seq. Investment Change TTM 0.47 % 0.47 % 0.57 % 1.27 % 7.37 %
Seq. Net Income Change TTM -8.24 % 2.27 % -21.51 % -67.1 % -0.8 %
Net Income (TTM) in Millions 1,004 1,094 1,069 1,363 4,142

EW Company Profile >> Back to EW Roi Comparisons >> See Annual EW Return On Investment



Return On Investment EW's Ranking
Within: No.
Industry # 38
Sector # 118
Overall # 928

Return On Investment Statistics
High Average Low
45.32 %
19.31 %
8.39 %
(Sep 30 2024)   (Jun 30 2026)







Financial Statements
Edwards Lifesciences's II. Quarter Investments $ 12,370 Millions EW's Balance sheet
Edwards Lifesciences's II. Quarter Income $ 241 Millions Quarterly EW's Income Statement
EW's Income by Division See EW's Income by Division


EW Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 11,884 11,615 8,237 7,270 7,470
Y / Y Investment Growth 2.32 % 41 % 13.3 % -2.68 % 17.77 %
Net Income in Millions 1,069 4,170 1,399 1,522 1,503
Y / Y Net Income Growth -74.35 % 197.96 % -8.05 % 1.25 % 82.55 %
Annual Return On Investment 9 % 35.9 % 16.99 % 20.93 % 20.12 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 9 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EW's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EW's Competitors
Subscribers only: Roi for Edwards Lifesciences's Suppliers
Subscribers only: Return On Investment for EW's Customers

Other Ratios
EW's Roa EW's Inventory Turnover Ratio EW's Growth Rates EW's Dividend Statistics
EW's Profitability Ratios EW's Asset Turnover Ratio EW's Dividend Growth
EW's Roe EW's Valuation Ratios EW's Financial Strength Ratios EW's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %

Date modified: 2026-09-26T06:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.